WHO adds an HPV vaccine for single-dose use

By Staff Reporter WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin® has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO’s 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose schedules. This important milestone will contribute to improving sustainable supply of HPV vaccines—allowing more girls to be reached with the vaccines that prevent cervical cancer. Unlike most other cancers, we have the ability to eliminate…

Read More

Single Dose Oral Cholera Vaccine Strategy Bears Fruit On the African Continent

By Michael Gwarisa Following indications of Global Shortages of the Oral Cholera Vaccine (OCV), the International Coordinating Group (ICG), the body which manages emergency supplies of vaccines announced a temporary suspension of the standard two-dose vaccination regimen in cholera outbreak response campaigns, using instead a single-dose approach. Despite fears from countries currently battling Cholera, the one-dose strategy has proven to be effective in responding to outbreaks, even though evidence on the exact duration of protection is limited, and protection appears to be much lower in children.  With a two-dose regimen,…

Read More